Pfizer and Biontech share prices rise

D.he fear of weakening economic stimuli and economic damage from the rampant corona pandemic weighed on the US stock exchanges on Friday. Shortly after the start of trading, the Dow Jones index of standard values ​​lost 0.3 percent to 29,383 points. The broader S&P 500 and the index of the technology exchange Nasdaq each fell 0.2 percent to 3573 and 11,882 points.

America’s Treasury Secretary Steven Mnuchin announced surprisingly that the multi-billion dollar corona aid created in the spring will expire on December 31. Experts spoke of a gap that will now open up to the inauguration of Democratic President-elect Joe Biden on January 20. “Markets will operate for about three weeks in January without the support they have had since spring,” said JP Morgan’s Michael Feroli.

The individual values ​​for Pfizer and Biontech were again up by 1.5 and 4.4 percent. The pharmaceutical company and the biotech company filed their expected application for an emergency approval for their corona vaccine with the American health authority FDA on Friday. In contrast, shareholders threw Gilead’s papers out of the depots. A panel of the World Health Organization (WHO) advises against the use of the remdesivir in Covid-19 patients with severe disease. The papers yielded 1.5 percent.

Nike shareholders could look forward to a twelve percent dividend increase. The share certificates of the sporting goods manufacturer went up by 1.1 percent.

Related Articles

Back to top button